Further evidence supporting the in vitro biocompatibility of a fatty acid-based deep eutectic solvent as a potential carrier for cannabidiol

Introduction Deep eutectic solvents (DESs) are increasingly explored as sustainable media for the extraction and formulation of plant-derived bioactives, yet their biological compatibility remains insufficiently characterized across human cell types. Here, we evaluated the cellular safety of a fatty acid-based DES and cannabidiol (CBD) prepared in this solvent using human keratinocyte (HaCaT) and hepatocyte-like (HepG2) models. Methods A two-phase approach combined MTS-based viability assessment and alkaline comet assay with measurements of reactive oxygen species (ROS), glutathione (GSH), and superoxide dismutase (SOD) activity following 24-h exposure. In Phase I, cells were exposed to the DES at 0.005–0.02% (v/v) and to the corresponding DES-based CBD formulations containing 0.24–0.98 μg/mL CBD. Results Both the DES and CBD formulation showed low cytotoxicity, with a significant viability reduction occurring only at the highest CBD concentration tested (0.98 μg/mL) in HepG2 cells. No evidence of treatment-induced DNA damage was observed in either cell line. In Phase II, CBD concentrations of 2.5, 5, and 10 μg/mL prepared in the DES were evaluated. Exposure at these concentrations did not significantly reduce HaCaT or HepG2 cell viability and no biologically relevant alterations in intracellular ROS, GSH levels, or SOD activity. DNA integrity was likewise preserved at the highest selected CBD concentration (10 μg/mL), while DES exposure alone showed no evidence of genotoxicity. Discussion Overall, the consistent absence of substantial cytotoxic, genotoxic, or redox-disrupting effects across two biologically distinct human cell models provides further evidence regarding the cellular safety of this fatty acid-based DES. By extending the assessment to oxidative stress and antioxidant defense endpoints, these findings provide a more comprehensive evaluation of its biological compatibility and further support its potential as a sustainable solvent and carrier platform for CBD and other plant-derived bioactive compounds.

Authors

Institutions

Publication Details

Journal
Frontiers in Medical Technology
Published
2026-11-19
DOI
https://doi.org/10.3389/fmedt.2026.2013545
Primary Topic
Ionic liquids properties and applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Further evidence supporting the in vitro biocompatibility of a fatty acid-based deep eutectic solvent as a potential carrier for cannabidiol

Maja Katalinić, Antonio Zandona, Nevenka Kopjar, Andreja Jurič et al.
Frontiers in Medical Technology
Ionic liquids properties and applications
article

Further evidence supporting the in vitro biocompatibility of a fatty acid-based deep eutectic solvent as a potential carrier for cannabidiol

Maja Katalinić, Antonio Zandona, Nevenka Kopjar, Andreja Jurič, Danijela Šeremet, Manuela Panić, Marko Obranović, Martin Češi, Ana Lucić Vrdoljak, Snježana Džijan
article en

Abstract

Introduction Deep eutectic solvents (DESs) are increasingly explored as sustainable media for the extraction and formulation of plant-derived bioactives, yet their biological compatibility remains insufficiently characterized across human cell types. Here, we evaluated the cellular safety of a fatty acid-based DES and cannabidiol (CBD) prepared in this solvent using human keratinocyte (HaCaT) and hepatocyte-like (HepG2) models. Methods A two-phase approach combined MTS-based viability assessment and alkaline comet assay with measurements of reactive oxygen species (ROS), glutathione (GSH), and superoxide dismutase (SOD) activity following 24-h exposure. In Phase I, cells were exposed to the DES at 0.005–0.02% (v/v) and to the corresponding DES-based CBD formulations containing 0.24–0.98 μg/mL CBD. Results Both the DES and CBD formulation showed low cytotoxicity, with a significant viability reduction occurring only at the highest CBD concentration tested (0.98 μg/mL) in HepG2 cells. No evidence of treatment-induced DNA damage was observed in either cell line. In Phase II, CBD concentrations of 2.5, 5, and 10 μg/mL prepared in the DES were evaluated. Exposure at these concentrations did not significantly reduce HaCaT or HepG2 cell viability and no biologically relevant alterations in intracellular ROS, GSH levels, or SOD activity. DNA integrity was likewise preserved at the highest selected CBD concentration (10 μg/mL), while DES exposure alone showed no evidence of genotoxicity. Discussion Overall, the consistent absence of substantial cytotoxic, genotoxic, or redox-disrupting effects across two biologically distinct human cell models provides further evidence regarding the cellular safety of this fatty acid-based DES. By extending the assessment to oxidative stress and antioxidant defense endpoints, these findings provide a more comprehensive evaluation of its biological compatibility and further support its potential as a sustainable solvent and carrier platform for CBD and other plant-derived bioactive compounds.

Frontiers in Medical TechnologyVol. 8
University of Zagreb (HR), Institute for Medical Research and Occupational Health (HR), University of Osijek (HR)
Ionic liquids properties and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon